Aucun résultat
Donna Senger is a Senior Investigator at the Lady Davis Institute for Medical Research, an Associate Professor in the Gerald Bronfman Department of Oncology at McGill University, and a founding scientist of Arch Cancer Therapeutics, a subsidiary of Arch Biopartners.
Professor Senger has had a long-standing interest on the development of pediatric and adult central nervous system (CNS) tumours including defining the molecular characteristics of invasive glioma, investigating cancer stem cells as therapeutic targets and understanding how the brain microenvironment impacts treatment.
More recently Pr. Senger’s research has focused on mechanisms important for the development of organ selective cancer metastasis, establishing in vivo cancer models for preclinical testing and identification and implementation of therapeutics for the treatment of sarcoma and metastatic melanoma.
Donna Senger’s specific research interests include:
De Boeck A, Ahn BY, D’Mello C, Lun X, Menon SV, Alsherhi M, Szulzewsky F, Shen Y, Khan L, Dang NH, Reichardt E, Goring KA, King J, Grisdale CJ, Grinshtein N, Hamardzumyan D, Reilly KM, Blough MD, Cairncross JG, Yong VW, Marra MA, Jones SJM, Kaplan DR, McCoy K, Holland EC, Bose P, Chan JA, Robbins SM, Senger DL. (2020) Nature Communications 2020 Oct 5;11(1):4997.
Rahn JJ, Lun X, Jorch SK, Hao X, Liane B, Venugopal C, Vora P, Ahn BY, Cairncross JG, Singh SK, Kubes P, Senger DL*, Robbins SM*. (2020) Biomaterials 2020 2020 Sep;252:120105. * Corresponding Authors.
Choudhury SR, Babes L, Rahn JJ, Ahn BY, Goring KAR, King JC, Lau A, Bjorn P, Hao X, Chojnacki AK, Thanabalasuriar A, McAvoy EF, Tabaries S, Schraeder C, Patel KD, Siegel PM, Schriemer DC, Muruve DA, Kelly MM, Yipp BG, Kubes P, Robbins SM, Senger DL. (2019) Cell 2019 Aug 22;178(5):1205-1221.e17.
Goh ETH, Lin A, Ahn BY, Lopes-Rodrigues V, Dang NH, Salim S, Berger B, Dymock B, Senger DL, Ibanez CF. (2018). Cell Chemical Biology Dec 20; 25(12):1485-1494.
You have the power to make a difference! Your gift will support vital research at the Lady Davis Institute for Medical Research (LDI) that will translate into disease prevention, improved diagnoses, earlier detection, new and enhanced therapies, a better quality of life, wellness and hope for all of us.
Faire la différence, vous avez ce don! Votre contribution soutiendra la recherche essentielle menée à l’Institut Lady Davis qui permettra la prévention des maladies, des diagnostics plus précis, des dépistages plus rapides, des traitements innovants et plus performants, une meilleure qualité de vie, le bien-être et l’espoir pour nous tous.
Copyright © 2024 | Lady Davis Institute for Medical Research/Jewish General Hospital
Conception et développement : Yankee Media